Challenges of Diagnosing Myeloproliferative Neoplasms

Ellen Ritchie, MD, Associate Professor of Clinical Medicine, Weill Cornell Medical College, discusses the challenges of diagnosing Myeloproliferative Neoplasms (MPNs). MPNs are rare, chronic blood cancers. Chronic conditions last for a long period of time and may...

Managing Patients With X-Linked Retinoschisis (XLRS)

David G. Birch, PhD, Chief Scientific and Executive Officer and Director of the Rose-Silverthorne Retinal Degenerations Laboratory, Retina Foundation of the Southwest discusses how patients suffering from X-Linked Retinoschisis (XLRS) are typically treated. X-linked...

Onxeo’s Orphan Oncology Pipeline

Philippe Maitre, Executive Vice President, US Operations for Onxeo discusses his company’s orphan oncology pipeline. The Company’s growth strategy is primarily driven by the development of its orphan oncology candidates which meet an established and unaddressed...

Actinium Pharmaceutical Update

Sandesh Seth discusses upcoming events of Actinium Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing and commercializing targeted therapies for safer myeloablation and conditioning of the bone marrow prior to a bone marrow transplant...

Still’s Disease Background

Len Walt, Vice President, Head of Medical Affairs, Sobi in North America, provides an overview of Still’s disease, a rare inflammatory disorder that affects the entire body, and how these patients typically present to their physicians. Still’s disease is...
  • Sign up
Lost your password? Please enter your username or email address. You will receive a link to create a new password via email.
We do not share your personal details with anyone.